Navigation Links
Corporate Financial Planning Experts Gather at IE – Innovation Enterprise’s Financial Planning & Analysis for Pharma & Biotech Summit
Date:2/21/2013

Philadelphia, Pennsylvania (PRWEB) February 21, 2013

Within an ever-changing business environment there is an unquestionable need for organizations to become analytically competitive, innovative and agile. Building on IE. – Innovation Enterprise’s history of successful summits in this sector, the Financial Planning & Analysis for Pharma & Biotech event will bring together over 200+ senior finance leaders in a unique, collaborative environment.

With over 25 distinguished keynote speakers including: Director, Finance, Pfizer, Senior Director, Finance, Johnson & Johnson and Senior Director, Finance, Siemens Healthcare, this summit will provide attendees with an exclusive insight into processes at the most forward thinking organizations currently in the industry.

Commenting on the 2012 event a previous attendee noted: “This summit is unique in that it covers both financially and industry relevant topics. It’s an excellent opportunity to share and exchange information and knowledge with high level and international professionals.” From the 120 delegates at last year’s event, over 80% recommended the event to a colleague with a further 87% rating the summit as “good to excellent”.

Emma Flanagan, International Events Director at IE. – Innovation Enterprise: “From our research into the market it became clear that finance leaders are looking for a forum to exchange ideas with peers of a similar stature and experience. This summit was specifically designed for senior level attendees. It’s exclusive, CPE accredited and we’re really proud of the agenda that we’ve organized.”

Running concurrently to the Pharma & Biotech summit is the Financial Planning & Analysis in Healthcare Summit where speakers from companies such as the American Academy of Physician Assistants and DaVita will be congregating to discuss their challenges and best practices in a no holds barred environment.

For a complete list of speakers, agenda and registration details for the Financial Planning & Analysis for Pharma & Biotech Summit please visit: http://finance.theiegroup.com/fpa-pharma

About IE.: The Innovation Enterprise Ltd, a CFO Publishing company is an independent business-to-business multi-channel media brand focused on the information needs of Senior Finance, Operations, Planning, Strategy, Decision Support & Advanced Analytics executives. Products include IE.Summits, IE.Finance, IE.Analytics, IE.Operations, IE.Strategy, IE.Membership and IE.Insights. Whether it's delivered online, or in person, everything IE produces reflects the company's unshakeable belief in the power of information to spur innovation.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10450140.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. China Cord Blood Corporation Announces Completion of Corporate Structure Consolidation
2. Novus Biologicals Hires David Eansor to Lead New Corporate-Development Effort
3. Amarantus Bioscience Launches Online Corporate Communication Channels
4. China Cord Blood Corporation to Further Consolidate its Corporate Structure
5. 2012 Battalia Winston Survey Finds Corporate Holiday Parties are Making a Comeback
6. Genomatica, Inc., Award-Winning Industrial Biotechnology Pioneer, Selects Alexandria Real Estate Equities, Inc. for Long-Term, Mission-Critical R&D Facility and Corporate Headquarters
7. CTI Appoints Monique Greer, Senior Vice President, Corporate Communications and Investor Relations
8. New "GMO Inside" Campaign Denounces Corporate Disinformation Campaign That Defeated Californias Prop 37
9. Amgen Names Ray Jordan Senior Vice President, Corporate Affairs
10. BioLife Solutions Completes Corporate Facilities Expansion, Build-Out of Additional cGMP Clean Room Manufacturing Suite
11. Amarantus BioSciences Corporate Overview to be Webcast Live Today from OneMedForum 2012 Conference in NYC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... ... February 04, 2016 , ... Franz Inc. , an ... technology has been recognized As “ Best in Semantic Web Technology - USA ... Corporate America, it’s our priority to showcase prominent professionals who are excelling in ...
(Date:2/3/2016)... , Feb. 3, 2016  With the ... patent cliff that is underway, therapies such as ... for a whole host of indications are in ... aid in the development and production of these ... poor quality and high costs, novel approaches and ...
(Date:2/3/2016)... ... February 03, 2016 , ... ProMIS Neurosciences is currently in ... to misfolded, propagating strains of Amyloid beta involved in Alzheimer’s disease. The Company ... , Following on from the first misfolded Amyloid beta target announced on Nov. ...
(Date:2/3/2016)... , ... February 03, 2016 , ... ... to aid in the rapid development and ongoing quality control of molecular assays ... outbreak is extremely high,” Dr. Gregory R. Chiklis, President and CEO of ZeptoMetrix, ...
Breaking Biology Technology:
(Date:1/18/2016)... , Jan. 18, 2016  Extenua Inc., ... that simplifies the use and access of ubiquitous ... go-to-market partnership with American Cyber.  ... extensive experience leading transformational C4ISR and Cyber initiatives ... integrating the latest proven technology solutions," said ...
(Date:1/13/2016)... , January 13, 2016 /PRNewswire/ ... announced the addition of the  "India ... Estimation & Forecast (2015-2020)"  report ... http://www.researchandmarkets.com/research/7h6hnn/india_biometrics ) has announced the addition ... Identification Market - Estimation & Forecast ...
(Date:1/8/2016)... and MANCHESTER, United Kingdom , Jan. 8, ... of innovative sensor-based diagnostic products, today announced the closing of ... and existing investors.  Proceeds from the financing will be used ... a hand-held device for detecting early-stage pressure ulcers. ... after receiving CE Mark approval. The device,s introduction ...
Breaking Biology News(10 mins):